Published in Cancer Res on October 01, 1978
Differential expression of type I and type II cyclic AMP-dependent protein kinases during cell cycle and cyclic AMP-induced growth arrest. Proc Natl Acad Sci U S A (1980) 1.05
Presence of free cyclic AMP receptor protein and regulation of its level by cyclic AMP in neuroblastoma-glioma hybrid cells. Proc Natl Acad Sci U S A (1979) 0.99
Effects of endocrine therapy on steroid-receptor content of breast cancer. Br J Cancer (1982) 0.96
Cyclic AMP binding proteins and prognosis in breast cancer. Br J Cancer (1990) 0.87
Differential β₂-adrenergic receptor expression defines the phenotype of non-tumorigenic and malignant human breast cell lines. Oncotarget (2014) 0.80
Rapid changes in specific estrogen binding elicited by cGMP or cAMP in cytosol from human endometrial cells. Proc Natl Acad Sci U S A (1983) 0.79
Cyclic adenosine 3',5'-monophosphate-binding proteins in human ovarian cancers. Br J Cancer (1994) 0.75
Mutations of the gene encoding the protein kinase A type I-alpha regulatory subunit in patients with the Carney complex. Nat Genet (2000) 6.26
Role of Agrobacterium cell envelope lipopolysaccharide in infection site attachment. Infect Immun (1976) 4.16
Autotaxin (NPP-2), a metastasis-enhancing motogen, is an angiogenic factor. Cancer Res (2001) 1.73
Involvement of microtubules in the regulation of Bcl2 phosphorylation and apoptosis through cyclic AMP-dependent protein kinase. Mol Cell Biol (1998) 1.70
Autotaxin (ATX), a potent tumor motogen, augments invasive and metastatic potential of ras-transformed cells. Oncogene (2000) 1.60
Feedback control of rat liver tryptophan pyrrolase. I. End product inhibition of trytophan pyrrolase activity. J Biol Chem (1967) 1.49
A transgenic mouse bearing an antisense construct of regulatory subunit type 1A of protein kinase A develops endocrine and other tumours: comparison with Carney complex and other PRKAR1A induced lesions. J Med Genet (2004) 1.46
cDNA cloning of the human tumor motility-stimulating protein, autotaxin, reveals a homology with phosphodiesterases. J Biol Chem (1994) 1.46
cAMP-dependent protein kinase: role in normal and malignant growth. Crit Rev Oncol Hematol (1995) 1.33
Antisense DNAs as multisite genomic modulators identified by DNA microarray. Proc Natl Acad Sci U S A (2001) 1.32
Stimulation of tumor cell motility linked to phosphodiesterase catalytic site of autotaxin. J Biol Chem (1996) 1.24
Autotaxin, tumor motility-stimulating exophosphodiesterase. Adv Enzyme Regul (1997) 1.20
Dual blockade of cyclic AMP response element- (CRE) and AP-1-directed transcription by CRE-transcription factor decoy oligonucleotide. gene-specific inhibition of tumor growth. J Biol Chem (1999) 1.20
Cyclic AMP-binding proteins: inverse relationship with estrogen-receptors in hormone-dependent mammary tumor regression. Eur J Biochem (1978) 1.16
Autoantibody biomarker opens a new gateway for cancer diagnosis. Biochim Biophys Acta (2006) 1.14
Overexpression of RII beta regulatory subunit of protein kinase A in human colon carcinoma cell induces growth arrest and phenotypic changes that are abolished by site-directed mutation of RII beta. Eur J Biochem (1996) 1.12
Cloning, chromosomal localization, and tissue expression of autotaxin from human teratocarcinoma cells. Biochem Biophys Res Commun (1996) 1.11
Hypothesis. Cyclic AMP and its receptor protein in tumor growth regulation in vivo. J Cyclic Nucleotide Res (1980) 1.10
Induction of multiple chemokine and colony-stimulating factor genes in experimental Burkholderia pseudomallei infection. Immunol Cell Biol (2001) 1.06
Protein kinase A (PK-A) regulatory subunit expression in colorectal cancer and related mucosa. Br J Cancer (1994) 1.06
Prognostic significance of the expression of a ras protein with a molecular weight of 21,000 by human breast cancer. Cancer Res (1987) 1.05
An antisense oligodeoxynucleotide targeted against the type II beta regulatory subunit mRNA of protein kinase inhibits cAMP-induced differentiation in HL-60 leukemia cells without affecting phorbol ester effects. Proc Natl Acad Sci U S A (1990) 1.04
Selective modulation of protein kinase isozymes by the site-selective analog 8-chloroadenosine 3',5'-cyclic monophosphate provides a biological means for control of human colon cancer cell growth. Proc Natl Acad Sci U S A (1988) 1.02
Differentiation of HL-60 leukemia by type I regulatory subunit antisense oligodeoxynucleotide of cAMP-dependent protein kinase. Proc Natl Acad Sci U S A (1991) 1.00
Extracellular protein kinase A as a cancer biomarker: its expression by tumor cells and reversal by a myristate-lacking Calpha and RIIbeta subunit overexpression. Proc Natl Acad Sci U S A (2000) 1.00
Types of cyclic AMP binding proteins in human breast cancers. Eur J Cancer (1993) 0.99
Amplified expression of p21 ras protein in hormone-dependent mammary carcinomas of humans and rodents. Biochem Biophys Res Commun (1985) 0.98
Anti-sense suppression of epidermal growth factor receptor expression alters cellular proliferation, cell-adhesion and tumorigenicity in ovarian cancer cells. Int J Cancer (2000) 0.98
An antisense oligodeoxynucleotide that depletes RI alpha subunit of cyclic AMP-dependent protein kinase induces growth inhibition in human cancer cells. Cancer Res (1993) 0.97
Cyclic adenosine 3':5-monophosphate receptor proteins in hormone-dependent and -independent rat mammary tumors. Cancer Res (1981) 0.96
8-Cl-cAMP induces cell cycle-specific apoptosis in human cancer cells. Int J Cancer (2001) 0.96
Relationship of hormone dependency to estrogen receptor and adenosine 3',5'-cyclic monophosphate-binding proteins in rat mammary tumors. J Natl Cancer Inst (1980) 0.94
Site-selective cyclic AMP analogs provide a new approach in the control of cancer cell growth. FEBS Lett (1987) 0.94
Inhibition of growth and modulation of gene expression in human lung carcinoma in athymic mice by site-selective 8-Cl-cyclic adenosine monophosphate. Cancer Res (1989) 0.94
Cancer. Checkpoint for invasion. Nature (2000) 0.94
Growth arrest and morphological change of human breast cancer cells by dibutyryl cyclic AMP and L-arginine. Science (1981) 0.93
CRE-transcription factor decoy oligonucleotide inhibition of MCF-7 breast cancer cells: cross-talk with p53 signaling pathway. Biochemistry (2000) 0.93
Site-selective cyclic AMP analogs as new biological tools in growth control, differentiation, and proto-oncogene regulation. Cancer Invest (1989) 0.91
Regulatory effects of nicotinamide on tryptophan pyrrolase synthesis in rat liver in vivo. Eur J Biochem (1968) 0.91
The regulatory subunit of cAMP-dependent protein kinase as a target for chemotherapy of cancer and other cellular dysfunctional-related diseases. Pharmacol Ther (1993) 0.90
Synergistic inhibition of growth of breast and colon human cancer cell lines by site-selective cyclic AMP analogues. Cancer Res (1988) 0.90
A single-injection protein kinase A-directed antisense treatment to inhibit tumour growth. Nat Med (1995) 0.90
Unhydrolyzable analogues of adenosine 3':5'-monophosphate demonstrating growth inhibition and differentiation in human cancer cells. Cancer Res (1992) 0.90
Enzymatic activation of autotaxin by divalent cations without EF-hand loop region involvement. Biochem Pharmacol (2001) 0.88
Adenosine receptor mediates motility in human melanoma cells. Biochem Biophys Res Commun (1998) 0.87
The RI alpha subunit of protein kinase A controls serum dependency and entry into cell cycle of human mammary epithelial cells. Oncogene (1994) 0.87
Experimental gene therapy of human colon cancer. Surgery (1994) 0.87
Protection against group A streptococcal infection by vaccination with self-adjuvanting lipid core M protein peptides. Vaccine (2005) 0.86
In vivo inhibition of tumor growth by cyclic adenosine 3',5'-monophosphate derivatives. Cancer Res (1974) 0.86
Role of site-selective cAMP analogs in the control and reversal of malignancy. Pharmacol Ther (1991) 0.86
Dibutyryl cyclic AMP mimics ovariectomy: nuclear protein phosphorylation in mammary tumor regression. Science (1977) 0.86
Suppression of malignancy targeting the intracellular signal transducing proteins of cAMP: the use of site-selective cAMP analogs, antisense strategy, and gene transfer. Life Sci (1991) 0.86
Site-selective 8-chloroadenosine 3',5'-cyclic monophosphate inhibits transformation and transforming growth factor alpha production in Ki-ras-transformed rat fibroblasts. FEBS Lett (1989) 0.85
8-chloroadenosine 3',5'-monophosphate (8-Cl-cAMP) selectively eliminates protein kinase A type I to induce growth inhibition in c-ras-transformed fibroblasts. Eur J Cancer (1998) 0.85
Type II regulatory subunit of protein kinase restores cAMP-dependent transcription in a cAMP-unresponsive cell line. J Biol Chem (1990) 0.85
Dual anticancer activity of 8-Cl-cAMP: inhibition of cell proliferation and induction of apoptotic cell death. Biochem Biophys Res Commun (2000) 0.85
In vivo inhibition of growth of two hormone-dependent mammary tumors by dibutyryl cyclic AMP. Science (1974) 0.84
Synergistic effects of 8-chlorocyclic-AMP and retinoic acid on induction of apoptosis in Ewing's sarcoma CHP-100 cells. Clin Cancer Res (1998) 0.84
Point mutation of the autophosphorylation site or in the nuclear location signal causes protein kinase A RII beta regulatory subunit to lose its ability to revert transformed fibroblasts. Proc Natl Acad Sci U S A (1995) 0.83
Cyclocreatine inhibits stimulated motility in tumor cells possessing creatine kinase. Int J Cancer (1998) 0.83
Induction of megakaryocytic differentiation and modulation of protein kinase gene expression by site-selective cAMP analogs in K-562 human leukemic cells. Proc Natl Acad Sci U S A (1989) 0.83
Apoptosis, growth arrest and suppression of invasiveness by CRE-decoy oligonucleotide in ovarian cancer cells: protein kinase A downregulation and cytoplasmic export of CRE-binding proteins. Mol Cell Biochem (2001) 0.83
On the mechanism of cyclic AMP-mediated growth arrest of solid tumors. Adv Cyclic Nucleotide Res (1980) 0.83
Participation of type II protein kinase A in the retinoic acid-induced growth inhibition of SH-SY5Y human neuroblastoma cells. J Cell Physiol (2000) 0.83
Arrest of hormone-dependent mammary cancer growth in vivo and in vitro by cholera toxin. Cancer Res (1983) 0.82
Oligonucleotide sequence-specific inhibition of gene expression, tumor growth inhibition, and modulation of cAMP signaling by an RNA-DNA hybrid antisense targeted to protein kinase A RIalpha subunit. Antisense Nucleic Acid Drug Dev (2000) 0.82
Downregulation of mdr-1 expression by 8-Cl-cAMP in multidrug resistant MCF-7 human breast cancer cells. J Clin Invest (1995) 0.82
Growth arrest and induction of apoptosis in breast cancer cells by antisense depletion of protein kinase A-RI alpha subunit: p53-independent mechanism of action. Mol Cell Biochem (1999) 0.82
Biochemical characterization of extracellular cAMP-dependent protein kinase as a tumor marker. Biochem Biophys Res Commun (2000) 0.82
Cripto-1-induced increase in vimentin expression is associated with enhanced migration of human Caski cervical carcinoma cells. Exp Cell Res (2000) 0.82
Regression of hormone-dependent mammary tumors in Sprague-Dawley rats as a result of tamoxifen or pharmacologic doses of 17 beta-estradiol: cyclic adenosine 3',5'-monophosphate-mediated events. J Natl Cancer Inst (1981) 0.82
Reverse transformation of Harvey murine sarcoma virus-transformed NIH/3T3 cells by site-selective cyclic AMP analogs. J Biol Chem (1988) 0.82
Synergistic effects of retinoic acid and 8-Cl-cAMP on apoptosis require caspase-3 activation in human ovarian cancer cells. Oncogene (1999) 0.81
Antagonistic action between cyclic adenosine 3':5'-monophosphate and estrogen in rat mammary tumor growth control. Cancer Res (1978) 0.81